Background Spinal cord stimulation (SCS) has become a cornerstone of neuromodulatory interventions for chronic pain, offering ...
This study is the first of its kind in developing an off-label indication for RLS. Other conditions we’re considering ...
As the local anesthetic faded after surgery, Sean Forsberg waited for the pain to come back. The 39-year-old Surrey resident ...
Spinal cord stimulators can significantly improve patients' lives. The province doesn't fund nearly enough of them, experts ...
Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing ...
As spine leaders look ahead to 2026, enthusiasm around regenerative medicine and neuromodulation continues to build. But much of the conversation still flattens a field that is far more complex than ...
Regionally, North America leads, followed by Europe, with fast growth in Asia-Pacific. Challenges include high costs, surgery ...
A new study published in Neuromodulation (1) demonstrates that automatic, daily remote monitoring of spinal cord stimulation (SCS) devices enables the first real-time visibility into post-implant ...
Gobsmacked, astonished, I realize that learned helplessness almost prevented me from getting the full benefits of my spinal stimulator.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results